Connect Biopharma Holdings Limited Ordinary Shares CNTB
$2.55
+0.39%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $7.29
- Implied Upside
- +185.7%
- Price Target Range
- $4.00 – $10.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-09 | OppenheimerMazahir Alimohamed |
Initiates coverage on | Outperform | $8 |
| 2026-06-26 | Piper SandlerBiren Amin |
Initiates coverage on | Neutral → Overweight | $7 |
| 2026-06-25 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $7 |
| 2026-05-26 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $6 |
| 2026-05-21 | Cantor FitzgeraldOlivia Brayer |
Initiates coverage on | Overweight | $4 |
| 2026-04-01 | BTIGJulian Harrison |
Reiterates | Buy | $10 |
| 2026-03-31 | BTIGJulian Harrison |
Reiterates | Buy | $10 |
| 2025-12-01 | Lake StreetThomas Flaten |
Initiates coverage on | Buy | $9 |
| 2025-11-13 | BTIGJulian Harrison |
Reiterates | Buy | $10 |
| 2025-10-31 | BTIGJulian Harrison |
Initiates coverage on | Buy | $10 |
| 2025-08-13 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $7 |
| 2025-06-12 | HC Wainwright & Co.Brandon Folkes |
Assumes | Buy | $7 |
| 2025-04-01 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2025-03-31 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-09-06 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-06-13 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $8 |
| 2024-04-17 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $7 → $8 |
| 2024-03-04 | HC Wainwright & Co.Emily Bodnar |
Initiates coverage on | Buy | $7 |
| 2023-09-13 | Cantor FitzgeraldLouise Chen |
Reiterates | Overweight | $5 |
| 2023-02-08 | SVB LeerinkThomas Smith |
Maintains | Outperform | $9 → $7 |
| 2022-06-02 | Cantor FitzgeraldLouise Chen |
Initiates coverage on | Overweight | $5 |
| 2022-05-05 | Piper SandlerJoseph Catanzaro |
Downgrades | Overweight → Neutral | $25 → $2 |
| 2022-05-04 | SVB LeerinkThomas Smith |
Maintains | Outperform | $22 → $9 |
| 2022-01-06 | SVB LeerinkThomas Smith |
Maintains | Outperform | $32 → $22 |
| 2021-07-02 | CICC |
Initiates coverage on | Outperform | $27 |
| 2021-04-13 | JefferiesKelly Shi |
Initiates coverage on | Buy | $27 |
| 2021-04-13 | SVB LeerinkThomas Smith |
Initiates coverage on | Outperform | $32 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.55
- Market Cap
- $146.71 million
- 52-Week Range
- $1.09 – $3.82
- Average Volume
- 466K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.